|
|
» ÀÛ¼ºÀÚ : KSMCB | » ÀÛ¼ºÀÏ : 2005-11-08 | » Á¶È¸ : 742 |
» ÷ºÎÆÄÀÏ : | ÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù. |
¸®º¸ÇÙ»êºÐ°ú¿¡¼ ¡®RNA Therapeutics¡¯ ºÎÁ¦·Î ´ÙÀ½°ú °°ÀÌ Á¤±â ¿¬±¸È¸¸¦ °³ÃÖÇÕ´Ï´Ù.
ÃÖ±Ù siRNA, aptamer, ribozyme, antisense µî RNA ¹× ÇÙ»êÀ» ±â¹ÝÀ¸·Î ÇÑ Ä¡·áÁ¦ °³¹ßÀÌ È°¹ßÈ÷ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ƯÈ÷ 2004³â ¸»¿¡´Â VEGF¿¡ ´ëÇÑ aptamer°¡ (Macugen) ³ëÀμº Ȳ¹Ýº¯Áõ¿¡ ´ëÇÑ Ä¡·áÁ¦·Î¼ ¹Ì±¹ FDA¿¡ ½ÂÀεǴ µî RNA ±â¹Ý Ä¡·áÁ¦°¡ ¶Ù¾î³ ÀüÀÓ»ó, ÀÓ»ó È¿°ú¸¦ º¸ÀÌ°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ ÀúÈñ ºÐ°ú¿¡¼± ±¹³»¿Ü °ü·Ã ºÐ¾ßÀÇ Àú¸í ¿¬±¸ÀÚµéÀ» ¸ð½Ã°í ÃֽŠ±¹³»¿Ü ¿¬±¸µ¿ÇâÀÇ ÆÄ¾Ç ¹× ¿¬±¸³»¿ëÀÇ »óÈ£ ±³·ù¸¦ À§ÇÏ¿© ¿¬±¸È¸¸¦ ¿°íÀÚ ÇÕ´Ï´Ù. ÇÐȸ ¿©·¯ºÐµéÀÇ ¸¹Àº °ü½É°ú Âü¿©¸¦ ºÎŹµå¸³´Ï´Ù. ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ ÇÙ»êºÐ°ú ºÐ°úÀå ÀÌ¿µÈÆ (KAIST) ¹®ÀÇó: À̼º¿í (´Ü±¹´ë, 02-709-2905, SWL0208@dankook.ac.kr) Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ ¸®º¸ÇÙ»ê ºÐ°ú Á¤±â¿¬±¸È¸ - RNA Therapeutics – ½Ã°£: 2005³â 12¿ù 9ÀÏ (±Ý) ¿ÀÈÄ 2½Ã Àå¼Ò: ´Ü±¹´ëÇб³ ¼¿ïÄ·ÆÛ½º ¼°ü 1106È£ 2:00-2:10 Opening remark Chair: Seong-Wook Lee, Ph.D. (Dankook Univ) 2:10-3:00 Developing aptamer-antidote pairs for safer therapeutics Bruce Sullenger, Ph.D. Duke University Medical Center, USA 3:00-3:30 Massive functional genomics and target validation using large circular antisense & sense DNA libraries Jong-Gu Park, Ph.D. Keimyung University School of Medicine, WelGENE Inc. 3:30 – 3:40 Break Chair: Younghoon Lee, Ph.D. (KAIST) 3:40-4:30 Potential applications of expressed siRNA and miRNA for Medicine Nancy Lee, Ph.D. Beckman Research Institute of the City of Hope, USA 4:30-5:00 Therapeutic application of siRNA to KITENIN, a metastasis enhancing protein, for experimental gene therapy to colon cancer in mice Kyung Keun Kim, M.D., Ph.D. Chonnam National University Medical School 5:00-5:30 Reprogramming gene expression by trans-splicing ribozyme: Application to specific and efficient cancer gene therapy Seong-Wook Lee, Ph.D. Dankook University 5:30 Closing remark
**÷ºÎÆÄÀÏÀÇ ¾àµµ¸¦ È®ÀÎÇϼ¼¿ä**
|